| Name | Title | Contact Details |
|---|
Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., which is a global leader in developing, manufacturing, selling and distributing innovative diagnostic imaging agents and products. LMI provides a broad portfolio of products, which are primarily used for the diagnosis of cardiovascular diseases. LMI’s key products include the echocardiography contrast agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs. LMI is headquartered in North Billerica, Massachusetts, and has offices in Puerto Rico, Canada and Australia.
Corona-Temecula Orthopaedic Associates is a Corona, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Rochester Medical Corporation is a Stewartville, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
South Oaks Hospital and Broadlawn Manor is a Amityville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Coriell Institute for Medical Research is a Camden, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.